CREBBP c.6361_6396del ;(p.L2121_G2132del)

Variant ID: 16-3778651-TGCCAGGCTGGGGTTGCATGCCGGGCTGGGACTGGAG-T

NM_004380.2(CREBBP):c.6361_6396del;(p.L2121_G2132del)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.

Blood
Passet, Marie M; Kim, Rathana R; Gachet, Stéphanie S; Sigaux, François F; Chaumeil, Julie J; Galland, Ava A; Sexton, Thomas T; Quentin, Samuel S; Hernandez, Lucie L; Larcher, Lise L; Bergugnat, Hugo H; Ye, Tao T; Karasu, Nezih N; Caye, Aurélie A; Heizmann, Beate B; Duluc, Isabelle I; Chevallier, Patrice P; Rousselot, Philippe P; Huguet, Françoise F; Leguay, Thibaut T; Hunault, Mathilde M; Pflumio, Françoise F; Freund, Jean-Noël JN; Lobry, Camille C; Lhéritier, Véronique V; Dombret, Hervé H; Domon-Dell, Claire C; Soulier, Jean J; Boissel, Nicolas N; Clappier, Emmanuelle E
Publication Date: 2022-06-16

Variant appearance in text: CREBBP: 6361_6396del
PubMed Link: 35316324
Variant Present in the following documents:
  • 10.1182-2021014723_bloodbld2021014723-suppl1.pdf
  • bloodBLD2021014723-suppl1.pdf
View BVdb publication page